BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jiang L, Yan LN. Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation. World J Gastroenterol 2010; 16(20): 2468-2475 [PMID: 20503446 DOI: 10.3748/wjg.v16.i20.2468]
URL: https://www.wjgnet.com/1007-9327/full/v16/i20/2468.htm
Number Citing Articles
1
Elin Teppa, Francesca Nadalin, Christophe Combet, Diego Javier Zea, Laurent David, Alessandra Carbone. Coevolution analysis of amino-acids reveals diversified drug-resistance solutions in viral sequences: a case study of hepatitis B virusVirus Evolution 2020; 6(1) doi: 10.1093/ve/veaa006
2
Anthony S. Robbins, Derrick D. Cox, Lynt B. Johnson, Elizabeth M. Ward. Persistent disparities in liver transplantation for patients with hepatocellular carcinoma in the United States, 1998 through 2007Cancer 2011; 117(19): 4531 doi: 10.1002/cncr.26063
3
Andres F. Carrion, Paul Martin, Christopher O’Brien. Management of Patients with Chronic Hepatitis B Before and After Liver Transplantation: An UpdateCurrent Hepatitis Reports 2012; 11(2): 102 doi: 10.1007/s11901-012-0128-4
4
Marie A. Laryea, Kymberly D. Watt. Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantationLiver Transplantation 2012; 18(5): 514 doi: 10.1002/lt.23408
5
Allan GN Angus, Arvind H Patel. Immunotherapeutic Potential Of Neutralizing Antibodies Targeting Conserved Regions Of The HCV Envelope Glycoprotein E2Future Microbiology 2011; 6(3): 279 doi: 10.2217/fmb.11.9
6
Yin‐jie Gao, Min Zhang, Bo Jin, Fan‐ping Meng, Xue‐mei Ma, Zhen‐wen Liu, Hai‐bin Su, Jing‐min Zhao, Han‐wei Li. A clinical‐pathological analysis of hepatitis B virus recurrence after liver transplantation in Chinese patientsJournal of Gastroenterology and Hepatology 2014; 29(3): 554 doi: 10.1111/jgh.12404
7
Shu-Shan Zhao, Lan-Hua Tang, Xia-Hong Dai, Wei Wang, Rong-Rong Zhou, Li-Zhang Chen, Xue-Gong Fan. Comparison of the efficacy of tenofovir and adefovir in the treatment of chronic hepatitis B: A Systematic ReviewVirology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-111
8
Guang-Qin Xiao, Jia-Yin Yang, Lu-Nan Yan. Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinomaHepatobiliary & Pancreatic Diseases International 2015; 14(6): 588 doi: 10.1016/S1499-3872(15)60416-7
9
Haripriya Maddur, Josh Levitsky. Schiff's Diseases of the Liver2017; : 1127 doi: 10.1002/9781119251316.ch46
10
Kymberly D. S. Watt, Marie A. Laryea. Schiff's Diseases of the Liver2011; : 1152 doi: 10.1002/9781119950509.ch47
11
Ramin Raul Ossami Saidy, Franziska Eurich, Maximilian Paul Postel, Eva Maria Dobrindt, Jasper Feldkamp, Selina Johanna Schaper, Johann Pratschke, Brigitta Globke, Dennis Eurich. Clinical and Histological Long-Term Follow-Up of De Novo HBV-Infection after Liver TransplantationMedicina 2021; 57(8): 767 doi: 10.3390/medicina57080767
12
Guang-Qin Xiao, Jiu-Lin Song, Shu Shen, Jia-Yin Yang, Lu-Nan Yan. Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantationWorld Journal of Gastroenterology 2014; 20(31): 10953-10959 doi: 10.3748/wjg.v20.i31.10953
13
Matthew S. Chang, Robert S. Brown. Hepatitis B and Liver Transplantation: Update in Management before and after TransplantationCurrent Hepatitis Reports 2011; 10(4): 255 doi: 10.1007/s11901-011-0108-0